Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 551

1.

Publisher Correction: Electron magnetic reconnection without ion coupling in Earth's turbulent magnetosheath.

Phan TD, Eastwood JP, Shay MA, Drake JF, Sonnerup BUÖ, Fujimoto M, Cassak PA, Øieroset M, Burch JL, Torbert RB, Rager AC, Dorelli JC, Gershman DJ, Pollock C, Pyakurel PS, Haggerty CC, Khotyaintsev Y, Lavraud B, Saito Y, Oka M, Ergun RE, Retino A, Le Contel O, Argall MR, Giles BL, Moore TE, Wilder FD, Strangeway RJ, Russell CT, Lindqvist PA, Magnes W.

Nature. 2019 May;569(7757):E9. doi: 10.1038/s41586-019-1208-1.

PMID:
31073227
2.

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekmann F, Cross NB, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au EHK, Kieu A, James L, Craig JC.

J Am Soc Nephrol. 2019 Apr 30. pii: ASN.2018121232. doi: 10.1681/ASN.2018121232. [Epub ahead of print]

PMID:
31040191
3.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
4.

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.

Pollock C, Stefánsson B, Reyner D, Rossing P, Sjöström CD, Wheeler DC, Langkilde AM, Heerspink HJL.

Lancet Diabetes Endocrinol. 2019 Jun;7(6):429-441. doi: 10.1016/S2213-8587(19)30086-5. Epub 2019 Apr 13.

PMID:
30992195
5.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMoa1811744. [Epub ahead of print]

PMID:
30990260
6.

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE, Mehrotra R, Stevens PE, Wang AY, Cheung M, Wheeler DC, Winkelmayer WC, Pollock CA; Conference Participants.

Kidney Int. 2019 Apr 12. pii: S0085-2538(19)30138-3. doi: 10.1016/j.kint.2019.01.017. [Epub ahead of print]

PMID:
30987837
7.

MMS observations of electron scale magnetic cavity embedded in proton scale magnetic cavity.

Liu H, Zong QG, Zhang H, Xiao CJ, Shi QQ, Yao ST, He JS, Zhou XZ, Pollock C, Sun WJ, Le G, Burch JL, Rankin R.

Nat Commun. 2019 Mar 4;10(1):1040. doi: 10.1038/s41467-019-08971-y.

8.

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study.

Lioufas N, Toussaint ND, Pedagogos E, Elder G, Badve SV, Pascoe E, Valks A, Hawley C; IMPROVE-CKD Writing Committee.

BMJ Open. 2019 Feb 21;9(2):e024382. doi: 10.1136/bmjopen-2018-024382.

9.

Validation of the Fitbit Flex in an Acute Post-Cardiac Surgery Patient Population.

Daligadu J, Pollock CL, Carlaw K, Chin M, Haynes A, Thevaraajah Kopal T, Tahsinul A, Walters K, Colella TJF.

Physiother Can. 2018 Fall;70(4):314-320. doi: 10.3138/ptc.2017-34.

PMID:
30745716
10.

Intravenous amino acid therapy for kidney protection in cardiac surgery patients: A pilot randomized controlled trial.

Pu H, Doig GS, Heighes PT, Allingstrup MJ, Wang A, Brereton J, Pollock C, Chesher D, Bellomo R.

J Thorac Cardiovasc Surg. 2018 Dec 15. pii: S0022-5223(18)33243-4. doi: 10.1016/j.jtcvs.2018.11.097. [Epub ahead of print]

PMID:
30685166
11.

Improving the quality of healthcare: a cross-sectional study of the features of successful clinical networks.

Haines MM, Brown B, D'Este CA, Yano EM, Craig JC, Middleton S, Castaldi PA, Pollock CA, Needham K, Watt WH, Elliott EJ, Scott A, Dominello A, Klineberg E, Atkinson JA, Paul C, Redman S.

Public Health Res Pract. 2018 Dec 6;28(4). pii: 28011803. doi: 10.17061/phrp28011803.

12.

SIRT1 Attenuates Kidney Disorders in Male Offspring Due to Maternal High-Fat Diet.

Nguyen LT, Mak CH, Chen H, Zaky AA, Wong MG, Pollock CA, Saad S.

Nutrients. 2019 Jan 11;11(1). pii: E146. doi: 10.3390/nu11010146.

13.

Kinetic Range Spectral Features of Cross Helicity Using the Magnetospheric Multiscale Spacecraft.

Parashar TN, Chasapis A, Bandyopadhyay R, Chhiber R, Matthaeus WH, Maruca B, Shay MA, Burch JL, Moore TE, Giles BL, Gershman DJ, Pollock CJ, Torbert RB, Russell CT, Strangeway RJ, Roytershteyn V.

Phys Rev Lett. 2018 Dec 28;121(26):265101. doi: 10.1103/PhysRevLett.121.265101.

PMID:
30636132
14.

Challenging Standing Balance Reduces the Asymmetry of Motor Control of Postural Sway Poststroke.

Pollock CL, Hunt MA, Vieira TM, Gallina A, Ivanova TD, Garland SJ.

Motor Control. 2019 Jan 1:1-17. doi: 10.1123/mc.2017-0098. [Epub ahead of print]

PMID:
30599808
15.

Electron-scale dynamics of the diffusion region during symmetric magnetic reconnection in space.

Torbert RB, Burch JL, Phan TD, Hesse M, Argall MR, Shuster J, Ergun RE, Alm L, Nakamura R, Genestreti KJ, Gershman DJ, Paterson WR, Turner DL, Cohen I, Giles BL, Pollock CJ, Wang S, Chen LJ, Stawarz JE, Eastwood JP, Hwang KJ, Farrugia C, Dors I, Vaith H, Mouikis C, Ardakani A, Mauk BH, Fuselier SA, Russell CT, Strangeway RJ, Moore TE, Drake JF, Shay MA, Khotyaintsev YV, Lindqvist PA, Baumjohann W, Wilder FD, Ahmadi N, Dorelli JC, Avanov LA, Oka M, Baker DN, Fennell JF, Blake JB, Jaynes AN, Le Contel O, Petrinec SM, Lavraud B, Saito Y.

Science. 2018 Dec 21;362(6421):1391-1395. doi: 10.1126/science.aat2998. Epub 2018 Nov 15.

16.

Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics.

van der Plas WY, Engelsman AF, Umakanthan M, Mather A, Sidhu SB, Delbridge LW, Pollock C, Waugh D, Sywak MS, Kruijff S.

Surgery. 2019 Jan;165(1):135-141. doi: 10.1016/j.surg.2018.04.092. Epub 2018 Nov 6.

PMID:
30413324
17.

Author reply.

Hong FS, Mo A, Nasra F, Sieradzki N, Pollock C, Willcox A, Smith C, Ho WK.

Intern Med J. 2018 Nov;48(11):1413-1414. doi: 10.1111/imj.14098. No abstract available. Erratum in: Intern Med J. 2018 Dec;48(12):1555.

PMID:
30387313
18.

SIRT1 overexpression attenuates offspring metabolic and liver disorders as a result of maternal high-fat feeding.

Nguyen LT, Chen H, Zaky A, Pollock C, Saad S.

J Physiol. 2019 Jan;597(2):467-480. doi: 10.1113/JP276957. Epub 2018 Oct 31.

PMID:
30381838
19.

Energy partitioning constraints at kinetic scales in low-β turbulence.

Gershman DJ, F-Viñas A, Dorelli JC, Goldstein ML, Shuster J, Avanov LA, Boardsen SA, Stawarz JE, Schwartz SJ, Schiff C, Lavraud B, Saito Y, Paterson WR, Giles BL, Pollock CJ, Strangeway RJ, Russell CT, Torbert RB, Moore TE, Burch JL.

Phys Plasmas. 2018;25(2). pii: 022303. doi: 10.1063/1.5009158. Epub 2018 Feb 20.

20.

A lance through the orbit.

Tinker D, Pollock C, Mendelsohn D, Dolman PJ.

Can J Ophthalmol. 2018 Oct;53(5):e196-e198. doi: 10.1016/j.jcjo.2017.12.007. Epub 2018 Feb 13. No abstract available.

PMID:
30340742

Supplemental Content

Loading ...
Support Center